Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-06-07

Clinical Trial Update: Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung [Phase 2]

View source ↗

Summary

Phase II neoadjuvant trial comparing nab-paclitaxel/carboplatin with paclitaxel/carboplatin in stage IIb and IIIA squamous cell carcinoma of the lung; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abraxane (paclitaxel albumin-bound)
  • CARBOPLATIN (Carboplatin)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN